Nice post dia....some words that give a little glimpse into a big Bavi future.
"We are pleased that PS and the PS receptor pathway have attracted an increasing amount of attention among cancer immunotherapy researchers and that PS is now seen as both an upstream immune checkpoint and novel drug target in this promising new area of cancer treatment."
We need a partner to get the funding to develop the IP. The money we give up in splitting revenues will be made up by the size of the development pie and the sped up time to market.
News 
Market Data 
Discover 
